Skip to content
MarketScale
‹ Back to IndustriesSciences

‘Everything Everywhere All At Once’ Reminds Scientists and Metaphysicians That Researching the Multiverse Has Important Thematic Fundamentals

The multiverse theory has been the subject of scientific research and philosophical debate for decades. It is a theory that suggests the existence of multiple universes beyond our own, each with its own unique physical laws and properties. Along with the recent phase of the Marvel Cinematic Universe, 2023’s Best Picture-winning film Everything Everywhere All…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · Everything Everywhere All at OnceExistenceFilmMetaphysics
Share

Key takeaways

01

The multiverse theory has been the subject of scientific research and philosophical debate for decades.

02

It is a theory that suggests the existence of multiple universes beyond our own, each with its own unique physical laws and properties.

03

Along with the recent phase of the Marvel Cinematic Universe, 2023’s Best Picture-winning film Everything Everywhere All…

The multiverse theory has been the subject of scientific research and philosophical debate for decades. It is a theory that suggests the existence of multiple universes beyond our own, each with its own unique physical laws and properties. Along with the recent phase of the Marvel Cinematic Universe, 2023’s Best Picture-winning film Everything Everywhere All At Once has brought this concept to a wider audience and reignited discussions about the nature of the multiverse. Where do the preeminent experts in this field, both scientists and metaphysicians, land in their current research and understanding of the multiverse?

While the multiverse theory is often discussed within the context of science and physics, it has also been explored within religious and spiritual traditions. Some religions, such as Hinduism and Buddhism, propose the existence of multiple realms or planes of existence beyond our own. These realms may be inhabited by deities, spirits, or other beings.

There are also scientific studies that suggest the multiverse theory may have implications for the nature of consciousness and reality itself. Some physicists have suggested that the existence of multiple universes could help explain the concept of quantum entanglement, where particles appear to be connected in ways that cannot be explained by traditional physics.

While multiverse theory is still a subject of debate and speculation, its exploration continues to provide insights into the nature of the universe and our place within it. As physicians and the larger scientific community continue to posit new perspectives and assessments as to the validity of the theory, there may be some more esoteric fundamentals that can widen the science community’s foundations for why exploring the multiverse is so fascinating and important to begin with. Mike Mantic, co-founder of personal consciousness exploration company Pathfinders, offers his insights on the thematic throughlines present in Everything Everywhere All At Once, and why they’re so important to understanding and researching the metaphysical nature of the multiverse.

Mike’s Thoughts:

“As a shamanic and older states of consciousness practitioner, I’m a strong supporter in the primacy of lived experience and the power of our consciousness. This movie picked up on some major clues quantum physics has given us about the nature of existence, but I find those potentials are best explored and unraveled through consciousness exploration. In this space, we can explore the universes that branch off and the choices we make, even meet those other aspects of ourselves to see where those choices may have taken us. More importantly, we can use consciousness exploration to see how we show up in the universe as multi-dimensional beings, which goes beyond the scope of this movie, and tap into the knowledge, wisdom and ability that those other aspects of ourselves have developed in order to, as it says in the movie itself, live up to your ultimate potential.

So, these connections and explorations can provide unparalleled insight into who we are, fully expressed as that ultimate potential, and provide a guiding light for other consciousness explorers to expand their true nature and purpose, far beyond who we currently understand ourselves to be in this world. I’ve found that this level of consciousness exploration can give us a deeper understanding of how the universe is and the opportunity to explore new concepts, ideas, and possibilities that could potentially lead us as individuals and as a species into a more advanced future.

Now, the movie picks up on these themes, particularly alternate realities that come from the specific choices that we make in our lives, and that sort of splitting off of the universe into alternate realities. However, I reckon it could go so much further. I don’t think it’s quantum physics that’s going to come through with the answers for us as a species. I think it’s exploring our own consciousness and making changes internally.”

Article written by Sonia Gossai.

About the author

S
Sciences

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Sciences expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Sciences expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

The pharmaceutical industry is facing a significant challenge as over $300 billion in branded pharmaceutical revenue is set to lose patent protection by 2030. This revenue gap is driving the largest merger and acquisition cycle seen in a decade, with companies seeking external growth through acquisitions. This shift is impacting the entire life sciences supply chain, prompting strategic changes across the industry.

  • 01Over $300 billion in pharmaceutical revenue is at risk due to patent expirations by 2030.
  • 02Big Pharma is engaging in an aggressive cycle of mergers and acquisitions.
  • 03The acquisitions are reshaping the life sciences supply chain.

Jun 29, 2026

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I clinical study of an oral solid dose formulation designed using AI, cleared by the UK's MHRA and conducted at the company's UK facility. The trial—built on machine learning algorithms from partner Intrepid Labs and Quotient's Translational Pharmaceutics platform—aims to validate AI as a direct contributor to formulation design rather than just an upstream analytical tool. Benchling characterizes the broader moment as biotech entering a "builder phase," in which leading organizations embed AI capability at the bench level rather than running isolated pilots.

  • 01Quotient Sciences has dosed healthy volunteers in a Phase I study it describes as the first clinical evaluation of an AI-designed oral formulation, following approval from the UK's MHRA.
  • 02The formulation was developed using advanced machine learning algorithms from Intrepid Labs, integrated with Quotient Sciences' Translational Pharmaceutics platform.
  • 03Benchling identifies a sector-wide shift toward embedding AI capability directly at the bench, moving beyond isolated pilots to structural adoption across biotech R&D.

Jun 17, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512